Invention Grant
- Patent Title: Inhalable formulation of fluticasone propionate and albuterol sulfate
-
Application No.: US17410774Application Date: 2021-08-24
-
Publication No.: US11638710B2Publication Date: 2023-05-02
- Inventor: Brian Paul O'Neill , Hardik Kirtikumar Shah , Julian Alexander Blair , Chris David Edlin , Shane Michael McKeon
- Applicant: Norton (Waterford) Limited
- Applicant Address: IE Waterford
- Assignee: Norton (Waterford) Limited
- Current Assignee: Norton (Waterford) Limited
- Current Assignee Address: IE Waterford
- Agency: Pillsbury Winthrop Shaw Pittman, LLP
- Priority: GB2012742 20200814
- Main IPC: A61K31/569
- IPC: A61K31/569 ; A61K9/00 ; A61K9/16 ; A61K47/26 ; A61K31/137 ; A61M15/00
Abstract:
This invention relates to a fixed-dose dry powder inhalation formulation comprising fluticasone propionate and albuterol sulfate, together with an α-lactose monohydrate carrier. In the formulation, the albuterol sulfate stabilises fluticasone propionate.
Information query
IPC分类:
